STOCK TITAN

BD Names Pamela Spikner as Chief Accounting Officer and Controller

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

BD (NYSE: BDX) has appointed Pamela Spikner as senior vice president, chief accounting officer and controller, effective January 20. Reporting to CFO Chris DelOrefice, Spikner will oversee all accounting policy and financial reporting for the company.

Spikner brings over 25 years of experience in corporate finance and accounting. She joins BD from R1 RCM, Inc., where she served as chief accounting officer since July 2021, managing financial reporting, compliance, and strategic financial planning. Her previous roles include accounting leadership positions at Exelon for 12 years and assistant corporate controller at Hill-Rom Holdings. She started her career at PwC in the audit practice focusing on healthcare and insurance industries.

A certified public accountant (CPA) and certified internal auditor (CIA), Spikner holds a Bachelor of Science in Accounting from Indiana University of Pennsylvania.

Loading...
Loading translation...

Positive

  • Appointment of experienced executive with over 25 years in corporate finance and accounting
  • Strong healthcare industry background through positions at R1 RCM and Hill-Rom Holdings
  • Dual certification as CPA and CIA indicates high level of expertise in accounting and auditing

Negative

  • None.

News Market Reaction

-0.32%
1 alert
-0.32% News Effect

On the day this news was published, BDX declined 0.32%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

FRANKLIN LAKES, N.J., Jan. 10, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Pamela Spikner has been named senior vice president, chief accounting officer and controller, effective January 20.

In this role, Spikner will be responsible for all accounting policy and financial reporting for the company. She will report to Chris DelOrefice, executive vice president and chief financial officer.

"Pam has a proven track record of leadership in corporate finance and accounting, with a deep passion for building and leading high-performing teams," said DelOrefice. "Her more than 25 years of expertise will play a pivotal role in the continued leadership of the finance organization at BD."

Spikner joins BD from R1 RCM, Inc., which provides technology-enabled revenue cycle management solutions to health care providers, where she served as chief accounting officer since July 2021. In that role, she oversaw financial reporting and compliance, led strategic financial planning, implemented operational efficiency programs, among other responsibilities. She previously held various accounting leadership roles during her 12-year tenure at Exelon Corporation, a Fortune 200 company and the nation's largest utility company, and served as assistant corporate controller from July 2019 through July 2021 at Hill-Rom Holdings, Inc., a medical device company. She began her career in the audit practice of PwC, where she worked with clients in the health care and insurance industries. 

Pam holds a Bachelor of Science in Accounting from Indiana University of Pennsylvania. She is a certified public accountant (CPA) and a certified internal auditor (CIA). 

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Contacts:

 


Media:                                                                           

Investors:

Troy Kirkpatrick                                                             

Adam Reiffe

VP, Public Relations                                                         

Senior Director, Investor Relations

858.617.2361                                                               

201.847.6927         

troy.kirkpatrick@bd.com                                               

adam.reiffe@bd.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-names-pamela-spikner-as-chief-accounting-officer-and-controller-302347708.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will Pamela Spikner start as BD's (BDX) new Chief Accounting Officer?

Pamela Spikner will start as BD's Chief Accounting Officer on January 20, 2025.

What was Pamela Spikner's role before joining BD (BDX)?

Before joining BD, Pamela Spikner served as chief accounting officer at R1 RCM, Inc. since July 2021.

What are Pamela Spikner's responsibilities as BD's (BDX) new CAO?

As Chief Accounting Officer at BD, Spikner will be responsible for all accounting policy and financial reporting for the company.

What is Pamela Spikner's educational and professional background at BD (BDX)?

Spikner holds a BS in Accounting from Indiana University of Pennsylvania, is a CPA and CIA, with over 25 years of experience including roles at R1 RCM, Exelon , Hill-Rom Holdings, and PwC.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

59.22B
283.77M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES